Taibang Biological Group has raised $300M in total funding. Backed by Platinum Orchid, GIC, China Life.
Taibang Biological Group funding overview
Taibang Biological Group has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. The round record for Taibang Biological Group runs through 2022; nothing later has been disclosed. Investors on record include Platinum Orchid, GIC, China Life, Cinda Kunpeng. 4 distinct backers are named across the disclosed rounds.
Taibang Biological Group at a glance
Total raised
$300M
Latest round date
August 2022
Notable investors
Platinum Orchid, GIC, China Life, Cinda Kunpeng
Frequently asked about Taibang Biological Group funding
How much has Taibang Biological Group raised?
Taibang Biological Group has raised $300M in total disclosed funding across the rounds on record.
Who has invested in Taibang Biological Group?
Platinum Orchid, GIC, China Life, Cinda Kunpeng are named among the investors backing Taibang Biological Group.
What was the latest Taibang Biological Group funding round?
No round stage has been disclosed for Taibang Biological Group.
Where is Taibang Biological Group based?
No headquarters location is disclosed for Taibang Biological Group.
When did Taibang Biological Group last raise?
The last disclosed Taibang Biological Group round closed in August 2022.
Totals shown for Taibang Biological Group aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
Companies related to Taibang Biological Group (30)
